Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Piramal and The Carlyle Group announced CA Clover Intermediate II Investments has agreed to invest fresh equity capital for a 20% stake in Piramal Pharma that will contain its pharmaceutical businesses.
read more
Wednesday, October 31, 2018
Capua BioServices has announced the completion of the renovation of one of the recovery and purification plants, at its facility in Capua, Italy.
read more
Thursday, September 05, 2013
Capsugel and Bend Research announced today that they have entered into a definitive agreement for Capsugel to acquire Bend Research as part of its Dosage Form Solutions (DFS) business unit. The acquisition provides Capsugel DFS an industry leading ...
read more
Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral form of octreotide in clinical development. The drug candidate is in ...
read more
Wednesday, November 01, 2017
Capsugel announced expanded clinical trial capabilities at its Edinburgh facility in Scotland.
read more
Capsugel today announced that it has acquired Encap Drug Delivery. Based in Scotland, Encap’s focus on liquid and semi-solid encapsulation-based product development, and clinical and commercial manufacturing for the pharmaceutical industry, ...
read more
Tuesday, February 27, 2018
CapsCanada announced the addition of a new, state-of-the-art, dedicated hydroxypropyl methylcellulose capsule manufacturing facility.
read more
Wednesday, August 12, 2020
Caprion-HistoGeneX and Viroclinics-DDL have announced a partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.
read more
Tuesday, October 07, 2014
Leading research peptide manufacturer [2]Cambridge Research Biochemicals (CRB) announced today that it has signed a non-exclusive license with The Scripps Research Institute (TSRI) to add click chemistry services, namely the “click” labelling of ...
read more
Tuesday, October 22, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories Europe, B.V. (CML-Europe) is pleased to announce the successful completion of its first Food and Drug Administration inspection. The inspection included a pre-approval inspection and...
read more
Monday, November 04, 2013
Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, and AAIPharma Services, Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and ...
read more
Wednesday, January 17, 2018
Cambrex held an opening ceremony with AstraZeneca at its Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies for a key intermediate.
read more
Thursday, October 07, 2021
Cambrex announced that it is expanding its manufacturing center of excellence in High Point, NC. The $30+ million investment is designed to meet the continually growing demand for small molecule development and manufacturing services.
read more
Wednesday, November 25, 2020
Cambrex is expanding its mid-scale and large-scale API manufacturing capacity in Charles City, Iowa.
read more
Tuesday, September 25, 2018
Cambrex announced that it is to establish a center of excellence for API clinical supply and process development at its site in High Point, North Carolina.
read more